Project NextGen Selects Initial Vaccine Candidates and Awards Over $500 Million to Advance Development of Vaccines and Therapeutics
BARDA is awarding over $240 million to support Project NextGen clinical studies for COVID-19 vaccines, including investments in cold-chain sample management, genomic sequencing, and increased central laboratory capacity for sample testing.
UF Innovate | Accelerate client BioInfoExperts is among the recipients. BARDA provided $4 million to the startup to provide genomic sequencing of COVID-19.